Paracetamol: A Review of Guideline Recommendations
Open accessThe DOI matches its Crossref record; 153 of the 154 references it cites were found in a registry or an index.
Abstract
Musculoskeletal pain conditions are age-related, leading contributors to chronic pain and pain-related disability, which are expected to rise with the rapid global population aging. Current medical treatments provide only partial relief. Furthermore, non-steroidal anti-inflammatory drugs (NSAIDs) and opioids are effective in young and otherwise healthy individuals but are often contraindicated in elderly and frail patients. As a result of its favorable safety and tolerability record, paracetamol has long been the most common drug for treating pain. Strikingly, recent reports questioned its therapeutic value and safety. This review aims to present guideline recommendations. Paracetamol has been assessed in different conditions and demonstrated therapeutic efficacy on both acute and chronic pain. It is active as a single agent and is additive or synergistic with NSAIDs and opioids, improving their efficacy and safety. However, a lack of significant efficacy and hepatic toxicity have also been reported. Fast dissolving formulations of paracetamol provide superior and more extended pain relief that is similar to intravenous paracetamol. A dose reduction is recommended in patients with liver disease or malnourished. Genotyping may improve efficacy and safety. Within the current trend toward the minimization of opioid analgesia, it is consistently included in multimodal, non-opioid, or opioid-sparing therapies. Paracetamol is being recommended by guidelines as a first or second-line drug for acute pain and chronic pain, especially for patients with limited therapeutic options and for the elderly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is recommended for fever, acute pain, chronic pain, postoperative recovery, musculoskeletal disorders, pregnancy-associated discomfort, pediatric illnesses, and palliative care [ 2 ].”
From Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For short-term treatment of acute pain and fever robust evidence continues to support both its efficacy and comparative safety [ 1 , 2 , 20 ].”
From Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management (2026) · cites this paper as [2]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One thing that is already accepted in the scientific community is that paracetamol has almost no anti-inflammatory activity and does not cause the same adverse effects as NSAIDs do.5”
From An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although it was introduced in clinics more than 100 years ago,4 paracetamol remains the recommended first-line option for pain management by several scientific societies, and particularly in vulnerable populations such as geriatrics, children, patients with peptic ulcers, and pregnant women.5,6”
From An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Paracetamol continues to occupy a privileged position within healthcare systems despite growing uncertainty regarding its efficacy in many chronic pain conditions [ 2 , 9 , 18 ].”
From Paracetamol: A History of Assumptions, Errors, and Evidence Reversals in Pain Management (2026) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
Temel, J. S., Greer, J. A., Muzikansky, A., Gallagher, E. R., Admane, S., Jackson, V. A., Dahlin, C. M., Blinderman, C. D., Jacobsen, J., Pirl, W. F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000678 · Cited by 7,482 · cited 2×
“However, in cancer patients, early pain therapy is critical not only to reduce pain discomfort but slow the disease progression and improve survival [58].”
BackgroundHunter, D. J., & Bierma-Zeinstra, S. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30417-9 · Cited by 4,795
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
Hochberg, M. C., Altman, R. D., April, K. T., Benkhalti, M., Guyatt, G., McGowan, J., Towheed, T., Welch, V., Wells, G., & Tugwell, P. (2012) · Arthritis Care & Research · doi:10.1002/acr.21596 · Cited by 3,068
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24131 · Cited by 2,516
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41142 · Cited by 1,965
OARSI recommendations for the management of hip and knee osteoarthritis
Zhang, W., Nuki, G., Moskowitz, R. W., Abramson, S., Altman, R. D., Arden, N. K., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2010) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2010.01.013 · Cited by 1,700
Oliveira, C. B., Maher, C. G., Pinto, R. Z., Traeger, A. C., Lin, C.-W. C., Chenot, J.-F., van Tulder, M., & Koes, B. W. (2018) · European Spine Journal · doi:10.1007/s00586-018-5673-2 · Cited by 1,584 · cited 1×
“However, recently, paracetamol failed to show superiority over placebo, and questions have been raised about its safety [70].”
Background2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
van der Heijde, D., Ramiro, S., Landewé, R., Baraliakos, X., Van den Bosch, F., Sepriano, A., Regel, A., Ciurea, A., Dagfinrud, H., Dougados, M., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210770 · Cited by 1,568
Zhang, W., Doherty, M., Leeb, B. F., Alekseeva, L., Arden, N. K., Bijlsma, J. W., Dinçer, F., Dziedzic, K., Häuselmann, H. J., Herrero-Beaumont, G., et al. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062091 · Cited by 1,338
Wick, E. C., Grant, M. C., & Wu, C. L. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2017.0898 · Cited by 1,009 · cited 2×
“Paracetamol has a role in the multimodal approach [71].”
BackgroundPharmacological Management of Persistent Pain in Older Persons
American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02376.x · Cited by 1,008
Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
Fallon, M., Giusti, R., Aielli, F., Hoskin, P., Rolke, R., Sharma, M., & Ripamonti, C. I. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy152 · Cited by 954
A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly
Wongrakpanich, S., Wongrakpanich, A., Melhado, K., & Rangaswami, J. (2018) · Aging and disease · doi:10.14336/ad.2017.0306 · Cited by 917 · cited 3×
“However, at the same time, severe concerns have been raised about the organ toxicity by NSAIDs particularly in the elderly and the risk of abuse and overdose of opioids [4,5,9,10].”
BackgroundPharmacological Management of Persistent Pain in Older Persons
(2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00699.x · Cited by 916
Pergolizzi, J., Böger, R. H., Budd, K., Dahan, A., Erdine, S., Hans, G., Kress, H., Langford, R., Likar, R., Raffa, R. B., et al. (2008) · Pain Practice · doi:10.1111/j.1533-2500.2008.00204.x · Cited by 854
Nelson, A. E., Allen, K. D., Golightly, Y. M., Goode, A. P., & Jordan, J. M. (2014) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.11.012 · Cited by 820 · cited 10×
“LBP is the first cause of disability worldwide [70,116–119].”
BackgroundInfluentialZhang, W., Doherty, M., Arden, N., Bannwarth, B., Bijlsma, J., Gunther, K.-P., Hauselmann, H. J., Herrero-Beaumont, G., Jordan, K., Kaklamanis, P., et al. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.028886 · Cited by 785 · cited 1×
“NSAIDs should be considered in patients not responding to paracetamol and should be prescribed at the lowest effective dose and for the shortest duration [93].”
BackgroundGuidance on the management of pain in older people
(2013) · Age and Ageing · doi:10.1093/ageing/afs200 · Cited by 727
Paracetamol: New Vistas of an Old Drug
Bertolini, A., Ferrari, A., Ottani, A., Guerzoni, S., Tacchi, R., & Leone, S. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00250.x · Cited by 674
Mechanism of Action of Paracetamol
Graham, G. G., & Scott, K. F. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00008 · Cited by 648 · cited 3×
“Cholinergic, noradrenergic, opioid, and serotoninergic (5-HT) mechanisms are thought to be involved in the complex “central”, spinal and supraspinal, actions of paracetamol [18].”
BackgroundWhich chronic conditions are associated with better or poorer quality of life?
Sprangers, M. A. G., de Regt, E. B., Andries, F., van Agt, H. M. E., Bijl, R. V., de Boer, J. B., Foets, M., Hoeymans, N., Jacobs, A. E., Kempen, G. I. J. M., et al. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00204-3 · Cited by 642
Paice, J. A., Portenoy, R., Lacchetti, C., Campbell, T., Cheville, A., Citron, M., Constine, L. S., Cooper, A., Glare, P., Keefe, F., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.5206 · Cited by 599 · cited 1×
“The American Society of Clinical Oncology (ASCO) indicates that paracetamol may be prescribed to relieve chronic pain and improve function in cancer survivors in whom there are no contraindications including dangerous drug–drug interaction (evidence quality: intermediate; strength of recommendation: moderate) [128].”
BackgroundPendleton, A., Arden, N., Dougados, M., Doherty, M., Bannwarth, B., Bijlsma, J. W. J., Cluzeau, F., Cooper, C., Dieppe, P. A., Günther, K.-P., et al. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.12.936 · Cited by 575 · cited 1×
“For the management of knee OA, the European League against Rheumatism (EULAR) recommended paracetamol as the first and preferred long-term oral analgesic (Table 2) [92].”
BackgroundMarmura, M. J., Silberstein, S. D., & Schwedt, T. J. (2015) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.12499 · Cited by 568
Acetaminophen for osteoarthritis
Towheed, T., Maxwell, L., Judd, M., Catton, M., Hochberg, M. C., & Wells, G. A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004257.pub2 · Cited by 563 · cited 1×
“In a Cochrane review of 15 RCTs involving 5986 participants, paracetamol was superior to placebo in five out of seven RCTs with a 5% relative improvement from baseline and a number-needed-to-treat of four to 16 to achieve a pain improvement; treatment with paracetamol did not modify WOMAC outcome [86].”
BackgroundNon-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines
Arden, N. K., Perry, T. A., Bannuru, R. R., Bruyère, O., Cooper, C., Haugen, I. K., Hochberg, M. C., McAlindon, T. E., Mobasheri, A., & Reginster, J.-Y. (2021) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00523-9 · Cited by 558 · cited 1×
“Therefore, in the recently updated of the Osteoarthritis Research Society International (OARSI) guidelines for non-surgical management of OA, paracetamol was conditionally not recommended; oral and transdermal opioids were strongly not recommended as well, and oral NSAIDs were not endorsed for cardiovascular or frail…”
MethodHyllested, M., Jones, S., Pedersen, J. L., & Kehlet, H. (2002) · British Journal of Anaesthesia · doi:10.1093/bja/88.2.199 · Cited by 500 · cited 3×
“found that while it was less effective than NSAIDs in dental surgery, paracetamol was equally effective to NSAIDs in major surgery and orthopedic surgery; also, paracetamol enhanced analgesia when added to a NSAID, compared with NSAIDs alone [65].”
BackgroundAnalgesic-Antipyretic and Antiinflammatory Agents and Drugs Employed in the Treatment of Gout
Insel, P. (1996) · Medical Entomology and Zoology · Cited by 458
Högestätt, E. D., Jönsson, B. A. G., Ermund, A., Andersson, D. A., Björk, H., Alexander, J. P., Cravatt, B. F., Basbaum, A. I., & Zygmunt, P. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501489200 · Cited by 454 · cited 1×
“In particular, the drug is metabolized to N-arachidonoylaminophenol (AM404), which is a compound with multiple potential analgesic activities, including the blockade of neuronal uptake of anandamide and of neuronal sodium channels [20,23,26].”
BackgroundThe Global Burden of Musculoskeletal Pain—Where to From Here?
Blyth, F. M., Briggs, A. M., Schneider, C. H., Hoy, D. G., & March, L. M. (2019) · American Journal of Public Health · doi:10.2105/ajph.2018.304747 · Cited by 454 · cited 1×
“As a result of the rapid aging of the world population, the global impact of MSP and of related disability will steadily and markedly increase in the near future [1,3].”
BackgroundEFNS guideline on the treatment of tension‐type headache – Report of an EFNS task force
Bendtsen, L., Evers, S., Linde, M., Mitsikostas, D. D., Sandrini, G., & Schoenen, J. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03070.x · Cited by 453 · cited 1×
“The European Federation of Neurological Societies supports paracetamol as first-line treatment a high degree of evidence (level A) for tension-type headache [83].”
BackgroundAcetaminophen (APAP) hepatotoxicity—Isn’t it time for APAP to go away?
Lee, W. M. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.07.005 · Cited by 442 · cited 1×
“Furthermore, drug-induced liver injury is a diagnosis of exclusion that has been ascribed almost only to paracetamol [143].”
BackgroundWong, J. J., Côté, P., Sutton, D. A., Randhawa, K., Yu, H., Varatharajan, S., Goldgrub, R., Nordin, M., Gross, D. P., Shearer, H. M., et al. (2017) · European Journal of Pain · doi:10.1002/ejp.931 · Cited by 414
Roofthooft, E., Joshi, G. P., Rawal, N., Van de Velde, M., & the PROSPECT Working Group* of the European Society of Regional Anaesthesia and Pain Therapy and supported by the Obstetric Anaesthetists’ Association (2021) · Anaesthesia · doi:10.1111/anae.15339 · Cited by 355
Schjerning Olsen, A.-M., Fosbøl, E. L., Lindhardsen, J., Folke, F., Charlot, M., Selmer, C., Lamberts, M., Bjerring Olesen, J., Køber, L., Hansen, P. R., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.004671 · Cited by 335
Zhang, W., Jones, A., & Doherty, M. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.018531 · Cited by 321 · cited 1×
“reported a significant pain reduction by paracetamol [89].”
BackgroundManagement of Persistent Pain in the Older Patient: A Clinical Review
Makris, U. E., Abrams, R. C., Gurland, B., & Reid, M. C. (2014) · JAMA · doi:10.1001/jama.2014.9405 · Cited by 316 · cited 1×
“statements and concluded supporting a stepwise approach with paracetamol as first-line therapy for pain in the elderly [103].”
BackgroundAnger, M., Valovska, T., Beloeil, H., Lirk, P., Joshi, G. P., Van de Velde, M., Raeder, J., & the PROSPECT Working Group* and the European Society of Regional Anaesthesia and Pain Therapy (2021) · Anaesthesia · doi:10.1111/anae.15498 · Cited by 293
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors
Ottani, A., Leone, S., Sandrini, M., Ferrari, A., & Bertolini, A. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.015 · Cited by 279
Non-steroidal anti-inflammatory drugs
Carbone, C., Musumeci, T., & Pignatello, R. (2013) · Drug-Biomembrane Interaction Studies · doi:10.1533/9781908818348.281 · Cited by 269
Kadam, U. T., Jordan, K., & Croft, P. R. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.007526 · Cited by 265
O'Neil, C. K., Hanlon, J. T., & Marcum, Z. A. (2012) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2012.09.004 · Cited by 261 · cited 2×
“Nevertheless, when potential benefits and risks of harm are considered, paracetamol continues to be investigated and recommended as a first-line analgesic for older adults with mild-to-moderate pain [84,101].”
BackgroundSingle dose oral analgesics for acute postoperative pain in adults - an overview of Cochrane reviews
Moore, R. A., Derry, S., Aldington, D., & Wiffen, P. J. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008659.pub3 · Cited by 258 · cited 1×
“A systematic review of the peer-reviewed literature confirmed that the combined use of paracetamol and NSAIDs could significantly enhance the analgesic effects of either drug alone [75,76].”
BackgroundCancer Pain Assessment and Classification
Caraceni, A., & Shkodra, M. (2019) · Cancers · doi:10.3390/cancers11040510 · Cited by 256 · cited 3×
“Pain is frequent in cancer, affecting approximately 55% of patients undergoing anticancer treatment, and 66% of patients with advanced or terminal disease [57].”
BackgroundOsteoarthritis pain: nociceptive or neuropathic?
Thakur, M., Dickenson, A. H., & Baron, R. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.47 · Cited by 251 · cited 3×
“OA is primarily a degenerative joint disease characterized by cartilage damage and remodeling and inflammation of joint structures [43].”
BackgroundInfluentialAcetaminophen and the Cyclooxygenase-3 Puzzle: Sorting out Facts, Fictions, and Uncertainties
Kis, B., Snipes, J. A., & Busija, D. W. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.085431 · Cited by 250
The Assessment of Pain in Older People: UK National Guidelines
Schofield, P. (2018) · Age and Ageing · doi:10.1093/ageing/afx192 · Cited by 241
Pincus, T., Koch, G. G., Sokka, T., Lefkowith, J., Wolfe, F., Jordan, J. M., Luta, G., Callahan, L. F., Wang, X., Schwartz, T., et al. (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200107)44:7<1587::aid-art282>3.0.co;2-x · Cited by 229
McLachlan, A. J., Bath, S., Naganathan, V., Hilmer, S. N., Le Couteur, D. G., Gibson, S. J., & Blyth, F. M. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03847.x · Cited by 227
Pharmacologic Management of Acute Attacks of Migraine and Prevention of Migraine Headache
Snow, V., Weiss, K., Wall, E. M., Mottur-Pilson, C., & for the American Academy of Family Physicians and the American College of Physicians–American Society of Internal Medicine* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-10-200211190-00014 · Cited by 223 · cited 1×
“However, paracetamol is recommended for the treatment of migraine by most national and international societies including the American Headache Society, the American Academy of Fa-mily Physicians and the American College of Physicians–American Society of Internal Medicine, and the Ad Hoc Committee of the Italian Societ…”
BackgroundARONOFF, D., OATES, J., & BOUTAUD, O. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.09.009 · Cited by 222 · cited 1×
“Paracetamol acts as a non-competitive reversible inhibitor by reducing the peroxide site of the enzymes [16,19].”
BackgroundDiagnosis and Management of Headache: A Review
Robbins, M. S. (2021) · JAMA · doi:10.1001/jama.2021.1640 · Cited by 219 · cited 1×
“In the last few months, new published studies report the safe use of paracetamol in patients with chronic kidney disease [147], the significant efficacy of paracetamol for post-arthroplasty pain [148], the lesser efficacy of paracetamol than ibuprofen for post-laminectomy pain [149], the opioid-sparing effects of para…”
BackgroundSaragiotto, B. T., Machado, G. C., Ferreira, M. L., Pinheiro, M. B., Abdel Shaheed, C., & Maher, C. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012230 · Cited by 215
Trappe, T. A., Carroll, C. C., Dickinson, J. M., LeMoine, J. K., Haus, J. M., Sullivan, B. E., Lee, J. D., Jemiolo, B., Weinheimer, E. M., & Hollon, C. J. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00611.2010 · Cited by 196 · cited 1×
“2 g/day given during a 12-week knee extensor resistance training increases muscle and strength without altering muscle concentrations of muscle proteins, water, myosin heavy chain, and COX-1 and -2 [115].”
BackgroundSynergism between paracetamol and nonsteroidal anti-inflammatory drugs in experimental acute pain
Miranda, H. F., Puig, M. M., Prieto, J. C., & Pinardi, G. (2006) · Pain · doi:10.1016/j.pain.2005.11.012 · Cited by 186 · cited 4×
“Zeidan et al. formally determined the median ED50s of paracetamol and morphine alone and paracetamol and morphine combination using the Dixon and Mood up-and-down method in three groups of 30 patients undergoing moderately painful surgery; initial doses were 1.5 g and 5 mg in the paracetamol and morphine groups, and t…”
MethodInfluentialAcute Treatments for Episodic Migraine in Adults
VanderPluym, J. H., Singh, R. B. H., Urtecho, M., Morrow, A. S., Nayfeh, T., Roldan, V. D. T., Farah, M. H., Hasan, B., Saadi, S. M., Shah, S. H., et al. (2021) · JAMA · doi:10.1001/jama.2021.7939 · Cited by 184 · cited 1×
“In the last few months, new published studies report the safe use of paracetamol in patients with chronic kidney disease [147], the significant efficacy of paracetamol for post-arthroplasty pain [148], the lesser efficacy of paracetamol than ibuprofen for post-laminectomy pain [149], the opioid-sparing effects of para…”
BackgroundJibril, F., Sharaby, S., Mohamed, A., & Wilby, K. J. (2015) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.v68i3.1458 · Cited by 174
Non-prescription (OTC) oral analgesics for acute pain - an overview of Cochrane reviews
Moore, R. A., Wiffen, P. J., Derry, S., Maguire, T., Roy, Y. M., & Tyrrell, L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010794.pub2 · Cited by 174 · cited 1×
“A systematic review of the peer-reviewed literature confirmed that the combined use of paracetamol and NSAIDs could significantly enhance the analgesic effects of either drug alone [75,76].”
BackgroundItalian guidelines for primary headaches: 2012 revised version
Sarchielli, P., Granella, F., Prudenzano, M. P., Pini, L. A., Guidetti, V., Bono, G., Pinessi, L., Alessandri, M., Antonaci, F., Fanciullacci, M., et al. (2012) · The Journal of Headache and Pain · doi:10.1007/s10194-012-0437-6 · Cited by 167 · cited 1×
“However, paracetamol is recommended for the treatment of migraine by most national and international societies including the American Headache Society, the American Academy of Fa-mily Physicians and the American College of Physicians–American Society of Internal Medicine, and the Ad Hoc Committee of the Italian Societ…”
BackgroundParacetamol versus placebo for knee and hip osteoarthritis
Leopoldino, A. O., Machado, G. C., Ferreira, P. H., Pinheiro, M. B., Day, R., McLachlan, A. J., Hunter, D. J., & Ferreira, M. L. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013273 · Cited by 167 · cited 1×
“A recent Cochrane systematic review of 10 placebo-controlled RCTs involving 3541 patients stated that paracetamol alone provided only small clinical benefits at 3 weeks to 3 month follow-up and no increased risk of adverse events overall [99].”
BackgroundThe Aging Risk and Atherosclerosis: A Fresh Look at Arterial Homeostasis
Head, T., Daunert, S., & Goldschmidt-Clermont, P. J. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00216 · Cited by 166
Pathan, S. A., Mitra, B., Straney, L. D., Afzal, M. S., Anjum, S., Shukla, D., Morley, K., Hilli, S. A. A., Rumaihi, K. A., Thomas, S. H., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00652-8 · Cited by 161 · cited 1×
“1 mg/kg intravenous morphine intravenously [67].”
Low Back Pain and Lumbar Spine Osteoarthritis: How Are They Related?
Goode, A. P., Carey, T. S., & Jordan, J. M. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-012-0305-z · Cited by 159 · cited 1×
“Lumbar spine OA is the single leading cause of disability, with estimates ranging from 40% to 85% [39,40].”
BackgroundCommon Musculoskeletal Disorders in the Elderly: The Star Triad
Minetto, M. A., Giannini, A., McConnell, R., Busso, C., Torre, G., & Massazza, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041216 · Cited by 156 · cited 1×
“In the elderly, OA is almost constantly associated with sarcopenia and tendinopathies that both worsen joint stability and pathology [44].”
BackgroundQaseem, A., McLean, R. M., O’Gurek, D. T., Batur, P., Lin, K., & Kansagara, D. L. (2020) · Annals of Internal Medicine · doi:10.7326/m19-3602 · Cited by 154 · cited 15×
“Most MSP conditions increase with age.”
BackgroundInfluentialShorter, E., Sannicandro, A. J., Poulet, B., & Goljanek-Whysall, K. (2019) · Current Rheumatology Reports · doi:10.1007/s11926-019-0839-4 · Cited by 152 · cited 1×
“Aging entails a progressive loss of muscle volume and function that impacts joint stability and motility and favors cartilage degeneration [113].”
BackgroundNaloxone-Reversible Antinociception by Paracetamol in the Rat
Pini, L. A., Vitale, G., Ottani, A., & Sandrini, M. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36432-8 · Cited by 147 · cited 1×
“Naloxone and naltrexone, two μ-opioid receptor antagonists, reduce or abo-lish paracetamol analgesia in different animal pain models [25,26].”
BackgroundStockler, M. R., Vardy, J. L., Pillai, A., & Warr, D. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.122 · Cited by 145 · cited 2×
“Finally, in combination with weak or strong opioids, paracetamol provided clinically meaningful relief in patients with moderate or severe cancer pain [122,123].”
BackgroundUpdated guidelines for the management of paracetamol poisoning in Australia and New Zealand
Chiew, A. L., Reith, D., Pomerleau, A., Wong, A., Isoardi, K. Z., Soderstrom, J., & Buckley, N. A. (2020) · Medical Journal of Australia · doi:10.5694/mja2.50428 · Cited by 145
Lipton, R. B., Baggish, J. S., Stewart, W. F., Codispoti, J. R., & Fu, M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.22.3486 · Cited by 141 · cited 1×
“008) and of associated symptoms such as functional disability, photophobia, and phonophobia [79].”
BackgroundChronic Pain in the Elderly with Cognitive Decline: A Narrative Review
Cravello, L., Santo, S. G. D., Varrassi, G., Benincasa, D., Marchettini, P., de Tommaso, M., Shofany, J., Assogna, F., Perotta, D., Palmer, K., et al. (2019) · Pain and Therapy · doi:10.1007/s40122-019-0111-7 · Cited by 138
Bussières, A., Cancelliere, C., Ammendolia, C., Comer, C. M., Zoubi, F. A., Châtillon, C.-É., Chernish, G., Cox, J. M., Gliedt, J. A., Haskett, D., et al. (2021) · Journal of Pain · doi:10.1016/j.jpain.2021.03.147 · Cited by 136 · cited 1×
“In the last few months, new published studies report the safe use of paracetamol in patients with chronic kidney disease [147], the significant efficacy of paracetamol for post-arthroplasty pain [148], the lesser efficacy of paracetamol than ibuprofen for post-laminectomy pain [149], the opioid-sparing effects of para…”
BackgroundInvolvement of Human Cytochrome P450 2D6 in the Bioactivation of Acetaminophen
Dong, H., Haining, R. L., Thummel, K. E., Rettie, A. E., & Nelson, S. D. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)13665-3 · Cited by 130 · cited 1×
“Based on the levels of CYP2D6 expression, individuals can be classified into “extensive”, “ultrarapid”, and “poor metabolizers” [30].”
BackgroundChronic low back pain: pharmacological, interventional and surgical strategies
Morlion, B. J. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.130 · Cited by 126 · cited 2×
“recommend paracetamol as a first-line treatment for LBP in patients of advanced age or with gastrointestinal, cardiovascular, or renal comorbidities [117].”
BackgroundThe Role of Opioid Analgesics in Geriatric Pain Management
Naples, J. G., Gellad, W. F., & Hanlon, J. T. (2016) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.06.006 · Cited by 121 · cited 1×
“In elderly painful conditions, the non-opioid analgesics such as paracetamol should be continued to facilitate “opioid-sparing” dosing [74].”
BackgroundThe development and hepatotoxicity of acetaminophen: reviewing over a century of progress
McGill, M. R., & Hinson, J. (2020) · Drug Metabolism Reviews · doi:10.1080/03602532.2020.1832112 · Cited by 117 · cited 1×
“They include oxidative stress, reactive nitrogen formation, and JNK activation [138].”
BackgroundCurrent etiological comprehension and therapeutic targets of acetaminophen-induced hepatotoxicity
Chowdhury, A., Jahan, N., Adelusi, T. I., & Wang, S. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105102 · Cited by 112 · cited 2×
“Guidelines for paracetamol overdose include charcoal for patients that can be treated early after ingestion and intravenous N-acetyl cysteine for patients at risk of hepatotoxicity [141].”
BackgroundThe efficacy and safety of paracetamol for pain relief: an overview of systematic reviews
Abdel Shaheed, C., Ferreira, G. E., Dmitritchenko, A., McLachlan, A. J., Day, R. O., Saragiotto, B., Lin, C., Langendyk, V., Stanaway, F., Latimer, J., et al. (2021) · Medical Journal of Australia · doi:10.5694/mja2.50992 · Cited by 110 · cited 2×
“Recently, Abdel Shaheed analyzed data from 36 publications and reported that paracetamol produced modest pain relief in hip and knee osteoarthritis, tension headache, and post-craniotomy pain and that it was ineffective in other conditions [145]; the authors concluded with the need for large, high-quality trials to re…”
BackgroundSafety of Paracetamol in Osteoarthritis: What Does the Literature Say?
Conaghan, P. G., Arden, N., Avouac, B., Migliore, A., & Rizzoli, R. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00658-9 · Cited by 101
Jones, P., Dalziel, S. R., Lamdin, R., Miles-Chan, J. L., & Frampton, C. M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007789.pub2 · Cited by 93 · cited 1×
“A Cochrane review on nine studies with 991 patients, comparing paracetamol with NSAIDs for acute soft tissue injury, found no clinically relevant differences (low-to-moderate quality evidence) between patients treated with paracetamol or with NSAIDs in pain-attenuating effects at day 1–7, swelling, and return to funct…”
BackgroundTemple, A. R., Benson, G. D., Zinsenheim, J. R., & Schweinle, J. E. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.02.004 · Cited by 86
Sandvik, R. K., Selbaek, G., Seifert, R., Aarsland, D., Ballard, C., Corbett, A., & Husebo, B. S. (2014) · European Journal of Pain · doi:10.1002/ejp.523 · Cited by 86 · cited 1×
“These benefits were confirmed in an RCT on nursing home patients with mild-to-moderate dementia; using a stepwise approach, pain treatment with paracetamol improved daily living [111].”
BackgroundChauhan, A., Sheriff, L., Hussain, M. T., Webb, G. J., Patten, D. A., Shepherd, E. L., Shaw, R., Weston, C. J., Haldar, D., Bourke, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15584-3 · Cited by 84 · cited 1×
“A key role is played by platelets that recruit macrophages and neutrophils; it has recently been shown that blocking the platelets C-type lectin-like receptor improves liver regeneration [136].”
BackgroundThe Role of Paracetamol in Chronic Pain: An Evidence-Based Approach
Nikles, C. J., Yelland, M., Del Mar, C., & Wilkinson, D. (2005) · American Journal of Therapeutics · doi:10.1097/00045391-200501000-00011 · Cited by 83 · cited 9×
“LBP is the first cause of disability worldwide [70,116–119].”
BackgroundInfluentialSEOM clinical guideline for treatment of cancer pain (2017)
Jara, C., del Barco, S., Grávalos, C., Hoyos, S., Hernández, B., Muñoz-Mateu, M., Quintanar, T., Meana, J. A., Rodriguez, C. A., & Peñas, R. D. L. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1791-2 · Cited by 82 · cited 2×
“The combination of paracetamol with strong opioids improves pain management and the sense of well-being [129].”
BackgroundReporting of age data in clinical trials of arthritis. Deficiencies and solutions
Rochon, P. A. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.2.243 · Cited by 79
Effective Pain Management in Patients with Dementia: Benefits Beyond Pain?
Flo, E., Gulla, C., & Husebo, B. S. (2014) · Drugs & Aging · doi:10.1007/s40266-014-0222-0 · Cited by 74
Oral paracetamol (acetaminophen) for cancer pain
Wiffen, P. J., Derry, S., Moore, R. A., McNicol, E. D., Bell, R. F., Carr, D. B., McIntyre, M., & Wee, B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012637.pub2 · Cited by 74 · cited 1×
“Nevertheless, a 2017 Cochrane review of three RCTs comparing paracetamol alone with placebo or paracetamol plus an opioid with the same dose of opioid alone concluded that there was a high risk of bias and no high-quality evidence to support or refute the use of paracetamol in patients with cancer pain of any intensit…”
BackgroundWoo, W. W. K., Man, S.-Y., Lam, P. K. W., & Rainer, T. H. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2005.01.023 · Cited by 72
Park, J. H., Hong, J., Han, K., Suh, S.-W., Park, S.-Y., Yang, J. H., & Han, S.-W. (2017) · Medicine · doi:10.1097/md.0000000000006372 · Cited by 66 · cited 1×
“MSP from multiple joint sites is a common occurrence [42].”
BackgroundGignac, M. A. M., Irvin, E., Cullen, K. L., Eerd, D. V., Beaton, D., Mahood, Q., McLeod, C., & Backman, C. L. (2019) · Arthritis Care & Research · doi:10.1002/acr.23855 · Cited by 64 · cited 1×
“The several environmental risk factors for lower limb OA include joint injury from high-impact sports and heavy work activities involving lifting, cumulative physical loads, full-body vibration, and bending/kneeling/squatting [41].”
BackgroundFuryk, J. S., Levas, D., Close, B., Laspina, K., Fitzpatrick, M., Robinson, K., Vangaveti, V., & Ray, R. (2017) · Emergency Medicine Journal · doi:10.1136/emermed-2017-206787 · Cited by 61 · cited 4×
“Paracetamol can be administered alone to treat mild-to-moderate pain [33,34].”
BackgroundInfluentialAssessment and Early Management of Pain in Hip Fractures: The Impact of Paracetamol
Dixon, J., Ashton, F., Baker, P. N., Charlton, K., Bates, C., & Eardley, W. (2018) · Geriatric Orthopaedic Surgery & Rehabilitation · doi:10.1177/2151459318806443 · Cited by 60
Hannon, C. P., Fillingham, Y. A., Browne, J. A., Schemitsch, E. H., Mullen, K. J., Casambre, F. D., Visvabharathy, V., Hamilton, W. G., & Valle, C. J. D. (2020) · The Journal of Arthroplasty · doi:10.1016/j.arth.2020.05.033 · Cited by 60
Westrich, G. H., Birch, G. A., Muskat, A., Padgett, D. E., Goytizolo, E. A., Bostrom, M. P., Mayman, D. J., Lin, Y., & YaDeau, J. T. (2019) · The Journal of Arthroplasty · doi:10.1016/j.arth.2019.02.030 · Cited by 58 · cited 5×
“Paracetamol was administered 30 min after admission to the post-anesthesia care unit and then every 6 h for three days or to discharge [34].”
BackgroundMethodResultInfluentialJaeschke, H., Murray, F. J., Monnot, A. D., Jacobson‐Kram, D., Cohen, S. M., Hardisty, J. F., Atillasoy, E. O., Hermanowski‐Vosatka, A., Kuffner, E. K., Wikoff, D. S., et al. (2020) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2020.104859 · Cited by 58 · cited 2×
“It binds to mitochondrial proteins, forming cytotoxic adducts, leading to mitochondrial dysfunction and severe hepatocellular necrosis [137].”
BackgroundCarroll, C. C., Dickinson, J. M., LeMoine, J. K., Haus, J. M., Weinheimer, E. M., Hollon, C. J., Aagaard, P., Magnusson, S. P., & Trappe, T. A. (2011) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01348.2010 · Cited by 57 · cited 1×
“have demonstrated that a 3-month resistance training and treatment with paracetamol 4 g/day versus placebo increased the cross-sectional area, deformation, and strain of the patellar tendon and decreased stiffness and modulus [114].”
BackgroundReporting of Age Data in Clinical Trials of Arthritis: Deficiencies and Solutions
Rochon, P. A. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410020091008 · Cited by 55
Jones, P., Dalziel, S. R., Lamdin, R., Miles-Chan, J. L., & FRAMPTON, C. M. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007789 · Cited by 53
Pharmacotherapies in Geriatric Chronic Pain Management
Marcum, Z. A., Duncan, N. A., & Makris, U. E. (2016) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.06.007 · Cited by 52 · cited 2×
“Nevertheless, when potential benefits and risks of harm are considered, paracetamol continues to be investigated and recommended as a first-line analgesic for older adults with mild-to-moderate pain [84,101].”
BackgroundRyan, C. G., McDonough, S., Kirwan, J. P., Leveille, S. G., & Martin, D. (2013) · European Journal of Pain · doi:10.1002/j.1532-2149.2013.00405.x · Cited by 48
Paracetamol and pain: the kiloton problem
Moore, R. A., & Moore, N. D. (2016) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2016-000952 · Cited by 48 · cited 1×
“Paracetamol is one of the most used drugs both over the counter and on prescription for pain and fever [11].”
BackgroundLeinisch, E., Evers, S., Kaempfe, N., Kraemer, C., Sostak, P., Jürgens, T., Straube, A., & May, A. (2005) · Pain · doi:10.1016/j.pain.2005.07.002 · Cited by 45 · cited 1×
“33% placebo; P = not significant) [80].”
Fenlon, S., Collyer, J., Giles, J., Bidd, H., Lees, M., Nicholson, J. E., Dulai, R. S., Hankins, M. C., & Edelman, N. L. (2012) · British Journal of Anaesthesia · doi:10.1093/bja/aes387 · Cited by 45 · cited 1×
“studied 130 patients treated with oral or intravenous paracetamol and oral or intravenous placebo for third molar extraction; there was no difference in the analgesic outcome of satisfactory analgesia at 1 postoperative h [35].”
BackgroundOral paracetamol (acetaminophen) for cancer pain
Wiffen, P. J., Derry, S., Moore, R. A., McNicol, E. D., Bell, R. F., Carr, D. B., McIntyre, M., & Wee, B. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012637 · Cited by 45
Ruggieri, V., Vitale, G., Pini, L. A., & Sandrini, M. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0284-9 · Cited by 44 · cited 2×
“In particular, the drug is metabolized to N-arachidonoylaminophenol (AM404), which is a compound with multiple potential analgesic activities, including the blockade of neuronal uptake of anandamide and of neuronal sodium channels [20,23,26].”
BackgroundVerkleij, S. P., Luijsterburg, P. A. J., Bohnen, A. M., Koes, B. W., & Bierma-Zeinstra, S. (2011) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2011.04.013 · Cited by 41 · cited 2×
“However, paracetamol was consistently associated with a better gastrointestinal safety profile than NSAIDs [88].”
BackgroundComparative Efficacy of Therapeutics for Chronic Cancer Pain: A Bayesian Network Meta-Analysis
Huang, R., Jiang, L., Cao, Y., Liu, H., Ping, M., Li, W., Xu, Y., Ning, J., Chen, Y., & Wang, X. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01567 · Cited by 41 · cited 1×
“Conversely, a 2019 network meta-analysis of analgesic drugs for chronic cancer pain concluded that the top-ranking drug classes for global efficacy were non-opioid analgesics, including paracetamol, as well as NSAIDs and opioids [126].”
BackgroundTropisetron blocks analgesic action of acetaminophen: A human pain model study
Bandschapp, O., Filitz, J., Urwyler, A., Koppert, W., & Ruppen, W. (2011) · Pain · doi:10.1016/j.pain.2011.02.003 · Cited by 39 · cited 2×
“Ondansetron and tropisetron, two 5-HT3 antagonists, abolish paracetamol analgesia in humans [23,24].”
BackgroundDolati, S., Tarighat, F., Pashazadeh, F., Shahsavarinia, K., Gholipouri, S., & Soleimanpour, H. (2020) · Anesthesiology and Pain Medicine · doi:10.5812/aapm.105754 · Cited by 38 · cited 1×
“In the last few months, new published studies report the safe use of paracetamol in patients with chronic kidney disease [147], the significant efficacy of paracetamol for post-arthroplasty pain [148], the lesser efficacy of paracetamol than ibuprofen for post-laminectomy pain [149], the opioid-sparing effects of para…”
BackgroundZeidan, A. M., Mazoit, J., Abdullah, M. A., Maaliki, H., Ghattas, T., & Saifan, A. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet306 · Cited by 37 · cited 2×
“The results demonstrated that paracetamol and morphine share, at least, additive analgesic effects [73].”
BackgroundCaughey, G. E., James, M. J., Proudman, S., & Cleland, L. G. (2010) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2010.05.032 · Cited by 36 · cited 1×
“Furthermore, in patients with rheumatoid arthritis, the co-administration of a fish oil containing the n-3 fatty acid, eicosapentaenoic acid enhanced the inhibition of COX-2 generated prostaglandin E2 [77].”
BackgroundHung, K. K. C., Graham, C. A., Lo, R. S. L., Leung, Y. K., Leung, L. Y., Man, S., Woo, W. K., Cattermole, G. N., & Rainer, T. H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192043 · Cited by 35 · cited 1×
“The authors concluded that the treatments were clinically effective without significant differences between groups [60].”
BackgroundRidderikhof, M. L., Lirk, P. B., Goddijn, H., Vandewalle, E., Schinkel, E., van Dieren, S., Kemper, E. M., Hollmann, M. W., & Goslings, J. C. (2017) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2017.08.041 · Cited by 33
Advances in pain management for older patients with cancer
Hachem, G. E., Rocha, F. O., Pepersack, T., Jounblat, Y., Drowart, A., & Lago, L. D. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.980 · Cited by 33 · cited 1×
“It is considered the first-choice drug for mild-to-moderate pain in older patients with cancer naïve to opioids [127].”
BackgroundSIAARTI recommendations for chronic noncancer pain.
Ambrosio, F., Finco, G., Mattia, C., Mediati, R. D., Paoletti, F. P., Coluzzi, F., Piacevoli, Q., Savoia, G., Amantea, B., Aurilio, C., et al. (2006) · PubMed · Cited by 32
Reasons why osteoarthritis predicts mortality: path analysis within a Cox proportional hazards model
Wilkie, R., Parmar, S., Bucknall, M., Smith, D., Thomas, M. J., Seale, B., Mansell, G., & Peat, G. (2019) · RMD Open · doi:10.1136/rmdopen-2019-001048 · Cited by 31 · cited 2×
“Increasing or maintaining motor activity may be protective against OA progression and the excess mortality associated with OA [46].”
BackgroundSchneider, J., Algharably, E. A. E., Budnick, A., Wenzel, A., Dräger, D., & Kreutz, R. H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229229 · Cited by 30
A systematic review and trial sequential analysis of intravenous vs. oral peri‐operative paracetamol
Mallama, M., Valencia, A., Rijs, K., Rietdijk, W. J. R., Klimek, M., & Calvache, J. A. (2020) · Anaesthesia · doi:10.1111/anae.15163 · Cited by 30 · cited 1×
“In a recent systematic review of 14 trials with 1695 participants on postoperative pain, there was no significant difference between intravenous and oral paracetamol in terms of pain intensity up to >24 postoperative h [36].”
BackgroundDiagnosis and management of headache.
Peatfield, R. C. (1989) · PubMed · Cited by 29
Fillingham, Y. A., Hannon, C. P., Erens, G. A., Mullen, K. J., Casambre, F. D., Visvabharathy, V., Hamilton, W. G., & Valle, C. J. D. (2020) · The Journal of Arthroplasty · doi:10.1016/j.arth.2020.05.037 · Cited by 29 · cited 1×
“After having critically reviewed 1287 publications yielding 17 publications representing the best available evidence for analysis on the efficacy and safety of paracetamol for total joint arthroplasty, the American Association of Hip and Knee Surgeons, American Academy of Orthopedic Surgeons (AAOS), Hip Society, Knee…”
MethodReid, M. C., Shengelia, R., & Parker, S. J. (2012) · HSS Journal® The Musculoskeletal Journal of Hospital for Special Surgery · doi:10.1007/s11420-012-9273-0 · Cited by 27
Shiffman, S. S., Battista, D. R., Kelly, J. P., Malone, M. K., Weinstein, R. B., & Kaufman, D. W. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13551 · Cited by 26
Arahata, M., & Asakura, H. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s174896 · Cited by 26
Intentional or Inadvertent Acetaminophen Overdose—How Lethal It Really Is?
Thusius, N. J., Romanowicz, M., & Bostwick, J. M. (2019) · Psychosomatics · doi:10.1016/j.psym.2019.05.001 · Cited by 24 · cited 2×
“In paracetamol overdose or when sulfate availability and/or activity of sulfotransferases are low, NAPQI is formed in excess [135].”
BackgroundPickering, G. P., Macian, N., Papet, I., Dualé, C., Coudert, C., & Pereira, B. (2018) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12437 · Cited by 23
Alternative Interacting Sites and Novel Receptors for Cannabinoid Ligands
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3_9 · Cited by 22
The brain signature of paracetamol in healthy volunteers: a double-blind randomized trial
Pickering, G., Kastler, A., Macian, N., Pereira, B., Valabregue, R., Lehericy, S., Boyer, L., Dubray, C., & Jean, B. (2015) · Drug Design, Development and Therapy · doi:10.2147/dddt.s81004 · Cited by 22 · cited 2×
“investigated the central antinociceptive effects of paracetamol in humans [27,28].”
BackgroundPsychosocial and behavioral factors in acetaminophen-related acute liver failure and liver injury
Pezzia, C., Sanders, C. M., Welch, S., Bowling, A., & Lee, W. M. (2017) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2017.08.006 · Cited by 22
Thakral, M., Shi, L., Foust, J. B., Patel, K. V., Shmerling, R. H., Bean, J. F., & Leveille, S. G. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly133 · Cited by 22 · cited 1×
“As a result of the rapid aging of the world population, the global impact of MSP and of related disability will steadily and markedly increase in the near future [1,3].”
BackgroundEffects of tapentadol on pain, motor symptoms and cognitive functions in Parkinson’s disease
Freo, U., Furnari, M., & Ori, C. (2018) · Journal of Pain Research · doi:10.2147/jpr.s164939 · Cited by 22 · cited 1×
“Although, opioids do not alter cognition in chronic pain patients when given at stable doses, their potential cognitive impact is a concern, especially in the elderly population [6,7].”
BackgroundSelf-citationRandomized controlled trials—a critical re-appraisal
Mielke, D., & Rohde, V. (2020) · Neurosurgical Review · doi:10.1007/s10143-020-01401-4 · Cited by 22 · cited 1×
“RCTs and other evidence should be analyzed critically by experts before adopting (or refusing) the results to daily clinical practice [155].”
BackgroundPrevalence of antiplatelet therapy in patients with diabetes
Miller, S. R., Littenberg, B., & MacLean, C. D. (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-18 · Cited by 20
Motter, F. R., Hilmer, S. N., & Paniz, V. M. V. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01408 · Cited by 19
Akbaş, S., Özkan, A., Durak, M. A., & Yologlu, S. (2021) · Neurochirurgie · doi:10.1016/j.neuchi.2021.04.019 · Cited by 19 · cited 1×
“In the last few months, new published studies report the safe use of paracetamol in patients with chronic kidney disease [147], the significant efficacy of paracetamol for post-arthroplasty pain [148], the lesser efficacy of paracetamol than ibuprofen for post-laminectomy pain [149], the opioid-sparing effects of para…”
BackgroundNICE keeps paracetamol in UK guidelines on osteoarthritis
Wise, J. (2014) · BMJ · doi:10.1136/bmj.g1545 · Cited by 17 · cited 2×
“The British Royal College of General Practitioners, the Primary Care Rheumatology Society, and the British Society for Rheumatology raised concerns about removing paracetamol from the recommended analgesics could result in unforeseen consequences from increased use of NSAIDs and opiates [102].”
BackgroundTropisetron and paracetamol association in post‐operative patients
Pickering, G. P., Faure, M., Commun, F., de Boissy, E. C., Roche, G., Mom, T., Simen, E., Dubray, C., Eschalier, A., & Gilain, L. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.00933.x · Cited by 16 · cited 1×
“Ondansetron and tropisetron, two 5-HT3 antagonists, abolish paracetamol analgesia in humans [23,24].”
BackgroundAn Approach to Drug-Induced Liver Injury from the Geriatric Perspective
Lee, B. T., Odin, J. A., & Grewal, P. (2021) · Current Gastroenterology Reports · doi:10.1007/s11894-021-00804-7 · Cited by 16
Köhler‐Forsberg, O., Sylvia, L. G., Thase, M. E., Calabrese, J. R., Deckersbach, T., Tohen, M. F., Bowden, C. L., McInnis, M. G., Kocsis, J. H., Friedman, E. S., et al. (2017) · Depression and Anxiety · doi:10.1002/da.22601 · Cited by 15 · cited 2×
“For example, it has been suggested that paracetamol may alter the therapeutic response to conventional antidepressants [133].”
BackgroundFreo, U., Furnari, M., Ambrosio, F., & Navalesi, P. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01586-0 · Cited by 15 · cited 1×
“Although, opioids do not alter cognition in chronic pain patients when given at stable doses, their potential cognitive impact is a concern, especially in the elderly population [6,7].”
BackgroundSelf-citationParacetamol for low back pain: the state of the research field
Koes, B. W., Schreijenberg, M., & Tkachev, A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1817738 · Cited by 15
Pickering, G. P., Macian, N., Dubray, C., & Pereira, B. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s111590 · Cited by 13 · cited 4×
“also showed that paracetamol positively affects cognition in decision making and working memory domains [28].”
BackgroundInfluentialOsteoarthritis: time for us all to shift the needle
Hunter, D. J. (2018) · Rheumatology · doi:10.1093/rheumatology/key065 · Cited by 13
Man, S., Woo, W., Lam, P., & Rainer, T. H. (2004) · Hong Kong Journal of Emergency Medicine · doi:10.1177/102490790401100203 · Cited by 12
Managing Pain in Chronically Ill Homebound Patients Through Home-Based Primary and Palliative Care
Major-Monfried, H., DeCherrie, L. V., Wajnberg, A., Zhang, M., Kelley, A. S., & Ornstein, K. A. (2018) · American Journal of Hospice and Palliative Medicine® · doi:10.1177/1049909118820846 · Cited by 12 · cited 1×
“In a 6-month study by the Mount Sinai Visiting Doctors who provide home-based primary and palliative care to home-bound patients >80 years, the prescription for patients with moderate-to-severe pain of opiates and paracetamol increased from baseline to the end of the study from 48% to 57% and 52% to 91%, respectively…”
BackgroundIdentification, assessment, and management of pain in patients with advanced dementia
Malotte, K. L., & McPherson, M. L. (2016) · Mental Health Clinician · doi:10.9740/mhc.2016.03.89 · Cited by 11
Ridderikhof, M. L., Saanen, J. B., Goddijn, H., van Dieren, S., van Etten‐Jamaludin, F. S., Lirk, P. B., Goslings, J. C., & Hollmann, M. W. (2019) · Emergency Medicine Journal · doi:10.1136/emermed-2019-208439 · Cited by 11 · cited 1×
“In a recent systematic review, paracetamol was found to be as effective as NSAIDs in treating acute MSP in patients with minor musculoskeletal injuries in terms of analgesic efficacy need for additional analgesia and adverse events (low quality of evidence) [69].”
BackgroundAt-a-glance - Trends in emergency department visits for acetaminophen-related poisonings: 2011–2019
Kaur, J., McFaull, S. R., & Bang, F. (2020) · Health Promotion and Chronic Disease Prevention in Canada · doi:10.24095/hpcdp.40.4.05 · Cited by 10
White, P. F. (2019) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2019.109625 · Cited by 9 · cited 3×
“found that a single preoperative administration of 1 g of oral paracetamol produced postoperative analgesia similar to 1 g of intravenous paracetamol in patients undergoing laparoscopic cholecystectomy [32].”
BackgroundInfluentialBlok, Z., Ridderikhof, M. L., Goddijn, H., Berendsen, M., & Hollmann, M. W. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.01.049 · Cited by 9 · cited 1×
“In a prospective cohort study in 116 patients presented to the Emergency Department of a level one trauma center because of fractures, strains, or sprains receiving opioids in the ambulance or during their stay in the Emergency Department, paracetamol did not modify morphine requirement in the acute phase or after dis…”
BackgroundStormholt, E. R., Steiness, J., Derby, C. B., Larsen, M. E., Maagaard, M., & Mathiesen, O. (2021) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.13943 · Cited by 7 · cited 1×
“However, large, authoritative clinical trials are costly, and it is unclear whether they will be done [145,146].”
BackgroundRamdin, C., Yu, C. H. Y., Colorado, J., & Nelson, L. S. (2021) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2021.05.056 · Cited by 3 · cited 4×
“In a double-blind RCT, a heterogeneous group of 87 patients of the Emergency Department with moderateto-severe pain (median age of 45 years, 60% females) were randomized to receive 1 g of paracetamol either intravenously or orally; the changes in Visual Analogue Score (VAS) for pain from baseline (67.9 ± 16.0 mm) to 3…”
BackgroundInfluential
Cited by
Sohail, R., Mathew, M., Patel, K. K., Reddy, S. A., Haider, Z., Naria, M., Habib, A., Abdin, Z. U., Razzaq Chaudhry, W., & Akbar, A. (2023) · Cureus · doi:10.7759/cureus.37080 · Cited by 239
“NSAIDs are commonly used for the management of conditions such as muscle pain, dysmenorrhea, arthritic conditions, pyrexia, gout, migraines, and as opioid-sparing agents in certain acute trauma cases [103].”
BackgroundAcademy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022
Mitchell, K. B., Johnson, H. M., Rodríguez, J. M., Eglash, A. R., Scherzinger, C., Widmer, K., Berens, P., & Miller, B. (2022) · Breastfeeding Medicine · doi:10.1089/bfm.2022.29207.kbm · Cited by 115
“Ibuprofen can be dosed 800 mg every 8 hours 37 and acetamino-phen/paracetamol 1,000 mg every 8 hours 38 in the acute setting.”
BackgroundRational Multimodal Analgesia for Perioperative Pain Management
Joshi, G. P. (2023) · Current Pain and Headache Reports · doi:10.1007/s11916-023-01137-y · Cited by 143
Mallet, C., Desmeules, J., Pegahi, R., & Eschalier, A. (2023) · Journal of Pain Research · doi:10.2147/jpr.s393809 · Cited by 83
“Although it was introduced in clinics more than 100 years ago,(4) paracetamol remains the recommended first-line option for pain management by several scientific societies, and particularly in vulnerable populations such as geriatrics, children, patients with peptic ulcers, and pregnant women.(5,6) Despite its wide us…”
BackgroundGhrayeb, A., Finney, A. C., Agranovich, B., Peled, D., Anand, S. K., McKinney, M. P., Sarji, M., Yang, D., Weissman, N., Drucker, S., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.013 · Cited by 87
Metadata
- Authors
- Freo, U., Ruocco, C., Valerio, A., Scagnol, I., & Nisoli, E.
- Affiliations
- University of Padua (IT)
- University of Milan (IT)
- University of Brescia (IT)
- Corresponding author
- Freo, Ulderico
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2021-07-31
- Volume
- 10
- Issue
- 15
- Pages
- 3420
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC8347233
- OpenAlex
- W3188836359
- Cited by
- 208
- References
- 154
- Citations by year
- 2026: 39 · 2025: 54 · 2024: 43 · 2023: 48 · 2022: 22 · 2021: 2
- FWCI
- 7.17
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Institutional Research Information System (Università degli Studi di Brescia) (submittedVersion, cc-by)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Funders
- Fondazione Cariplo (2016-1006)
- Fondazione Umberto Veronesi (2016-1006)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- paracetamol, musculoskeletal pain, chronic pain, acute pain, guideline recommendations, NSAID combination therapy, hepatotoxicity, genetic polymorphism, elderly patients, vulnerable patients, multimodal analgesia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

